IPOPLUS

₹754

▼ -20 -2.58%

11 May 2026

NSE Listed · Pharmaceuticals

Remus Pharmaceuticals Limited (REMUS)

Volume: 3,800Avg Vol 1W: 5,980Avg Vol 1M: 5,61852W Range:₹580₹2,279
NSE BSE
₹754▼ 2.58%
Key Ratios
Updated just now
Market Cap₹2,252 Cr
Current Price₹754
Previous Close₹774
High / Low (52w)₹2,279 / ₹580
Volume3,800
Avg Vol (1W)5,980
Avg Vol (1M)5,618
Stock P/E45.37
Book Value₹434.4
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth191.33%
Profit Margin—
Total Debt₹3 Cr
Shares Outstanding—
Face Value—
EPS (TTM)₹65.23
P/B1.74
Debt / Equity—
50 DMA₹653.81
200 DMA₹739.86
Day change-2.58%
Price Chart
₹754▼ 19.02% · 1Y
₹1136₹58541K
2025-06-17
2026-05-11

20-day avg volume: 6K shares

Pros
  • Revenue grew 190% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricMar 2026Mar 2025
Revenue₹453 Cr₹348 Cr
EBITDA₹34 Cr₹27 Cr
Net Profit₹19 Cr₹16 Cr
EPS20.8617.46
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS65.2142.9783.2434.3410.68.12
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Total Liabilities₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Equity₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Total Debt₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operating₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Free Cash Flow₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Shareholding
Promoter 70.95% Institutions 6.11% Public 22.93%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search